Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Humacyte, Inc. (HUMA)

Compare
1.4500
-0.0100
(-0.68%)
At close: April 3 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
114,398
114,398
96,940
84,578
81,208
Operating Income
-114,398
-114,398
-96,940
-84,578
-81,208
Net Non Operating Interest Income Expense
-5,173
-5,173
-1,132
-3,571
-4,332
Other Income Expense
-29,130
-29,130
-12,704
76,184
59,063
Pretax Income
-148,701
-148,701
-110,776
-11,965
-26,477
Net Income Common Stockholders
-148,701
-148,701
-110,776
-11,965
-26,477
Diluted NI Available to Com Stockholders
-148,701
-148,701
-110,776
-11,965
-26,477
Basic EPS
-1.26
--
-1.07
-0.12
-0.66
Diluted EPS
-1.26
--
-1.07
-0.12
-0.66
Basic Average Shares
118,479.0970
--
103,420.2380
103,051.3660
39,970.3980
Diluted Average Shares
118,479.0970
--
103,420.2380
103,051.3660
39,970.3980
Total Operating Income as Reported
-114,398
-114,398
-100,047
-84,578
-81,208
Total Expenses
114,398
114,398
96,940
84,578
81,208
Net Income from Continuing & Discontinued Operation
-148,701
-148,701
-110,776
-11,965
-26,477
Normalized Income
-119,571
-119,571
-98,072
-88,149
-85,540
Interest Income
4,104
4,104
5,467
2,629
16
Interest Expense
9,277
9,277
6,599
6,200
4,348
Net Interest Income
-5,173
-5,173
-1,132
-3,571
-4,332
EBIT
-139,424
-139,424
-104,177
-5,765
-22,129
EBITDA
-132,234
-132,234
-96,458
2,445
-13,888
Reconciled Depreciation
7,190
7,190
7,719
8,210
8,241
Net Income from Continuing Operation Net Minority Interest
-148,701
-148,701
-110,776
-11,965
-26,477
Total Unusual Items Excluding Goodwill
-29,130
-29,130
-12,704
76,184
59,063
Total Unusual Items
-29,130
-29,130
-12,704
76,184
59,063
Normalized EBITDA
-103,104
-103,104
-83,754
-73,739
-72,951
12/31/2021 - 12/1/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MIST Milestone Pharmaceuticals Inc.
0.7500
-6.61%
 
IBRX ImmunityBio, Inc.
2.9700
-2.62%
 
IOVA Iovance Biotherapeutics, Inc.
3.2500
-8.19%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.4432
-11.91%
 
DRMA Dermata Therapeutics, Inc.
0.9322
-5.84%
 
BLUE bluebird bio, Inc.
4.8900
-2.78%
 
GERN Geron Corporation
1.4700
-7.55%
 
CAPR Capricor Therapeutics, Inc.
9.27
-4.83%
 
SANA Sana Biotechnology, Inc.
1.3700
-15.95%
 
CADL Candel Therapeutics, Inc.
5.25
-1.13%